Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states
- PMID: 35013146
- PMCID: PMC8748675
- DOI: 10.1038/s41467-021-27322-4
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states
Abstract
Prostate cancer is the second most common malignancy in men worldwide and consists of a mixture of tumor and non-tumor cell types. To characterize the prostate cancer tumor microenvironment, we perform single-cell RNA-sequencing on prostate biopsies, prostatectomy specimens, and patient-derived organoids from localized prostate cancer patients. We uncover heterogeneous cellular states in prostate epithelial cells marked by high androgen signaling states that are enriched in prostate cancer and identify a population of tumor-associated club cells that may be associated with prostate carcinogenesis. ERG-negative tumor cells, compared to ERG-positive cells, demonstrate shared heterogeneity with surrounding luminal epithelial cells and appear to give rise to common tumor microenvironment responses. Finally, we show that prostate epithelial organoids harbor tumor-associated epithelial cell states and are enriched with distinct cell types and states from their parent tissues. Our results provide diagnostically relevant insights and advance our understanding of the cellular states associated with prostate carcinogenesis.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
A.K.S. reports compensation for consulting and/or SAB membership from Merck, Honeycomb Biotechnologies, Cellarity, Hovione, Repertoire Immune Medicines, Ochre Bio, Third Rock Ventures, Relation Therapeutics, and Dahlia Biosciences. F.Y.F. reports compensation for consulting and/or SAB membership from Astellas, Bayer, Blue Earth Diagnostics, Celgene, Genentech, Janssen Oncology, Myovant, Roivant, Sanofi, PFS Genomics, and SerImmune. The remaining authors declare no competing interests.
Figures








Similar articles
-
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.BJU Int. 2019 May;123 Suppl 5:27-35. doi: 10.1111/bju.14695. BJU Int. 2019. PMID: 30712320
-
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.Stem Cells Transl Med. 2017 Mar;6(3):748-760. doi: 10.5966/sctm.2016-0243. Epub 2016 Sep 29. Stem Cells Transl Med. 2017. PMID: 28297567 Free PMC article.
-
Club-like cells in proliferative inflammatory atrophy of the prostate.J Pathol. 2023 Sep;261(1):85-95. doi: 10.1002/path.6149. Epub 2023 Aug 7. J Pathol. 2023. PMID: 37550827 Free PMC article.
-
Heterogeneity and complexity of the prostate epithelium: New findings from single-cell RNA sequencing studies.Cancer Lett. 2022 Jan 28;525:108-114. doi: 10.1016/j.canlet.2021.10.035. Epub 2021 Oct 30. Cancer Lett. 2022. PMID: 34728312 Free PMC article. Review.
-
Fibroblast heterogeneity in prostate carcinogenesis.Cancer Lett. 2022 Jan 28;525:76-83. doi: 10.1016/j.canlet.2021.10.028. Epub 2021 Oct 29. Cancer Lett. 2022. PMID: 34715252 Free PMC article. Review.
Cited by
-
Identification of KLHL17 as a prognostic marker for prostate cancer based on single-cell sequencing and in vitro/in vivo experiments.Discov Oncol. 2024 Oct 4;15(1):524. doi: 10.1007/s12672-024-01406-1. Discov Oncol. 2024. PMID: 39365488 Free PMC article.
-
Metabolic imaging across scales reveals distinct prostate cancer phenotypes.Nat Commun. 2024 Jul 16;15(1):5980. doi: 10.1038/s41467-024-50362-5. Nat Commun. 2024. PMID: 39013948 Free PMC article.
-
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance.Nat Cancer. 2022 Sep;3(9):1071-1087. doi: 10.1038/s43018-022-00431-9. Epub 2022 Sep 5. Nat Cancer. 2022. PMID: 36065066 Free PMC article.
-
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine.Biomedicines. 2023 Oct 10;11(10):2743. doi: 10.3390/biomedicines11102743. Biomedicines. 2023. PMID: 37893116 Free PMC article. Review.
-
The evolving landscape of prostate cancer somatic mutations.Prostate. 2022 Aug;82 Suppl 1(Suppl 1):S13-S24. doi: 10.1002/pros.24353. Prostate. 2022. PMID: 35657155 Free PMC article. Review.
References
-
- Blau HM, et al. Plasticity of the differentiated state. Science. 1985;230:758–766. - PubMed
-
- Varga J, Greten FR. Cell plasticity in epithelial homeostasis and tumorigenesis. Nat. Cell Biol. 2017;19:1133–1141. - PubMed
-
- Boutros PC, et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 2015;47:736–745. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases